NCT02623946|Completed
Loading search results
Sponsor study identifier
observational
10
1 country
1
Study Start
November 2015
Actual (reported)Primary Completion
December 9, 2020
Actual (reported)Study Completion
February 2021
Actual (reported)Study Design: Phase 4, pilot, single center, observational study. MEP's will be obtained twice, two weeks apart at baseline and every 6 months for 36 months (total of 14 sessions of MEP's) MEP's will include:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2021
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2015
Actual (reported)November 30, 2015
Actual (reported)December 8, 2015
Actual (reported)December 9, 2020
Actual (reported)February 2021
Actual (reported)intrapatient correlation coefficient of MEP's
to measure within subject correlation a two-way fixed Intraclass Correlation (ICC) will be calculated for each of 10 participants across sessions measured two weeks apart. The ICC will provide an estimate of the variance of each individual's motor evoked potentials at each paired time point.
obtained between two assessments done two weeks apart
Correlation coefficient between the changes from baseline MEP results and clinical measures (EDSS, 6MW, T25FWT, 9HPT)
obtained every 6 months for 36 months
Correlation between the change in the conduction index and the change in clincal measures
obtained at baseline and every 6 months over 36 months
Patients with MacDonald criteria (2005) multiple sclerosis presently being treated with Alemtuzumab.
Clinique Neuro-Outaouais
Gatineau, Quebec, J8Y 1W2, Canada
Jacques FH, Apedaile BE, Danis I, Sikati-Foko V, Lecompte M, Fortin J. Motor Evoked Potential-A Pilot Study Looking at Reliability and Clinical Correlations in Multiple Sclerosis. J Clin Neurophysiol. 2024 May 1;41(4):357-364. doi: 10.1097/WNP.0000000000001003. Epub 2023 Mar 21.
Francois H Jacques, MD
Clinic Neuro-Outaouais; Director
10 participants (actual enrollment reported by the registry).
First Submitted
November 30, 2015
First Posted
December 8, 2015
Study Start
November 2015
Actual (reported)Attention/Working Memory Rehabilitation in Multiple Sclerosis: A Pilot Project Using Cogmed Working Memory Training
Contact the study team to confirm eligibility.
Primary Completion
December 9, 2020
Actual (reported)Study Completion
February 2021
Actual (reported)Last Updated
July 28, 2021
Record last verified: 2020-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: